Biopharma R&D and Clinical Trials Awards (BRCTA) APAC 2023
The Biopharma R&D and Clinical Trials Awards (BRCTA) seeks to give recognition to exceptional Asian clinical trials leaders, organizations and technologies over the past year. Asia is home to thriving research facilities and clinical research institutes, is the world choice for clinical trials and supports complex materials supply chains. Recognizing outstanding achievements of top clinical trials leaders in the industry, the Biopharma R&D and Clinical Trials Awards (BRCTA) applauds extraordinary leaders & trend-setters of today and inspires innovators of tomorrow. The Awards Ceremony will be held in conjunction with Clinical Trial Festival Asia.
How does it work?
IMAPAC, the organizing committee of Biopharma R&D and Clinical Trials Awards (BRCTA) has called for nomination from the IMAPAC biologics community for different biologics award categories. All entries and nominations were considered and submitted to the judging panel and market research team from IMAPAC. Based on the number of nominations and assessment, the top 5 entries under each category were shortlisted. From the top 5 entries, the award winner will be determined by 100 % voting results from the public or bioprocessing community.
TIMELINE OF AWARDS
Criteria for nomination
THE CRITERIA FOR A COMPANY TO BE ELIGIBLE FOR THE BIOPHARMA R&D AND CLINICAL TRIALS AWARDS(BRCTA) ARE:
- The company should be an organization that is involved in biopharmaceutical development and/or manufacturing
- The company should have a notable presence in APAC
- The company should have displayed significant developments in the past few years
CRITERIA TO WIN AWARDS
Based on the number of nominations and assessment, the top 5-7 entries under each category were shortlisted. From the top 5-7 entries, the award winner will be determined by 100 % voting results from the Biologics community. Companies with the most number of votes will win the award in their respective category.
Award Categories open for nominations
Best Clinical Research Institute 2022
Best Clinical Trial Software
Excellence in Clinical Biomarker Testing
Excellence in Clinical Trial Diversity and Inclusion
